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Background: Although adequate management of postoperative pain with oral analgesics is an important aspect of
surgical procedures, inadvertent overprescribing can lead to excess availability of opioids in the community for potential
diversion. The purpose of our study was to prospectively evaluate opioid consumption following outpatient upper-ex-
tremity surgical procedures to determine opioid utilization patterns and to develop prescribing guidelines.
Methods: All patients undergoing outpatient upper-extremity surgical procedures over a consecutive 6-month period
had the following prospective data collected: patient demographic characteristics, surgical details, anesthesia type, and
opioid prescription and consumption patterns. Analysis of variance and post hoc comparisons were performed using
t tests, with the p value for multiple pairwise tests adjusted by the Bonferroni correction.
Results: A total of 1,416 patients with a mean age of 56 years (range, 18 to 93 years) were included in the study.
Surgeons prescribed a mean total of 24 pills, and patients reported consuming a mean total of 8.1 pills, resulting in a
utilization rate of 34%. Patients undergoing soft-tissue procedures reported requiring fewer opioids (5.1 pills for 2.2
days) compared with fracture surgical procedures (13.0 pills for 4.5 days) or joint procedures (14.5 pills for 5.0 days)
(p < 0.001). Patients who underwent wrist surgical procedures required a mean number of 7.5 pills for 3.1 days and those
continued
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who underwent hand surgical procedures required a mean number of 7.7 pills for 2.9 days, compared with patients who
underwent forearm or elbow surgical procedures (11.1 pills) and those who underwent upper arm or shoulder surgical
procedures (22.0 pills) (p < 0.01). Procedure type, anatomic location, anesthesia type, age, and type of insurance were
also all signiﬁcantly associated with reported opioid consumption (p < 0.001).
Conclusions: In this large, prospective evaluation of postoperative opioid consumption, we found that patients
are being prescribed approximately 3 times greater opioid medications than needed following upper-extremity
surgical procedures. We have provided general prescribing guidelines, and we recommend that surgeons care-
fully examine their patients’ opioid utilization and consider customizing their opioid prescriptions on the basis of
anatomic location and procedure type to prescribe the optimal amount of opioids while avoiding dissemination of
excess opioids.
Although effective postoperative pain control is important,
the U.S. Centers for Disease Control and Prevention (CDC)
has reported that there is a growing epidemic of prescription
painkiller abuse1. In 2007 alone, there were 27,658 accidental
deaths related to prescription opioid overdose2. Furthermore,
according to the American Society of Consultant Pharmacists,
millions of pounds of “leftover” prescriptions go unused in
patients’ medicine cabinets each year in the United States3.
Many factors contribute to this problem, including an in-
creasingly aggressive culture of pain management, a lack of
prescribing guidelines for physicians, inconsistent periopera-
tive utilization of local anesthetics, and inadequate disposal
instructions for patients4.
Orthopaedic surgical procedures pose a unique chal-
lenge and opportunity in safe pain management. Speciﬁcally,
orthopaedic surgical procedures often result in greater post-
operative pain than other surgical procedures because of
the manipulation of musculoskeletal tissue5. Orthopaedic
surgeons routinely prescribe opioids for postoperative pain
management, yet little is known about the typical opioid re-
quirements for various orthopaedic procedures. During a
2014 American Academy of Orthopaedic Surgeons (AAOS)
symposium, it was recognized through an audience survey
that most orthopaedic surgeons do not know how many pills
to prescribe to their patients and/or how many pills their
patients actually take6. This may result in inconsistent and
often excessive opioid-prescribing patterns. A greater under-
standing of opioid consumption patterns can result in more
optimal and safer prescribing habits by physicians and can
decrease the risk for overprescribing and potential diversion
or abuse.
The purpose of our study was to prospectively eval-
uate opioid consumption following outpatient upper-
extremity surgical procedures. The goal was to determine
opioid utilization patterns to help to develop prescribing
guidelines.
Materials and Methods
After obtaining institutional review board approval, 9 hand surgery fellowship-
trained, board-certiﬁed orthopaedic surgeons practicing in a single private
academic group prospectively collected postoperative opioid consumption data
for 6 consecutive months (in April 2014 to October 2014). Data were collected
via a standardized intake form. The surgeons were not blinded, were asked to
continue their normal prescribing patterns, and were aware that the patients
would be asked about their opioid consumption postoperatively. Nicotine use
information was not collected. On the day of the surgical procedure, the sur-
geon recorded the following variables on the intake form: the patient’s age and
sex, the procedure’s anatomic location (hand or wrist, forearm or elbow, and
upper arm or shoulder), the procedure type (soft-tissue surgical procedure,
joint surgical procedure, or fracture surgical procedure), the anesthesia type
(local, sedation, general, and/or regional), the opioid type prescribed, and the
quantity of the opioid prescribed.
Patients were included if they had an outpatient surgical procedure of
the hand, wrist, elbow, forearm, or shoulder. Patients undergoing inpatient
procedures were excluded. At the ﬁrst postoperative visit, the following data
were solicited directly from the patient by a member of the research team and
were added to the standardized intake form: the quantity of the prescribed
opioid used, the total days of opioid use, the reason for discontinuation (the
opioids no longer being necessary or the side effects associated with the opi-
oids), and the side effects (if any). Finally, patients were asked if opioid disposal
instructions were given to them at any point in time. A research team member
collected the intake form, and the data were subsequently entered into a central
database.
The opioids prescribed and studied in this study included Percocet
(oxycodone and acetaminophen) or an oxycodone 5-mg equivalent, Vicodin
(acetaminophen and hydrocodone) or a hydrocodone 5-mg equivalent, and
Tylenol #3 (acetaminophen and codeine) with 30 mg of codeine. For the pur-
poses of this study, each of these prescription opioid pills was treated as equiv-
alent to the other.
The following surgical data were collected: the type of procedure and
the type of anesthesia. The type of procedure was subcategorized as a soft-
tissue procedure (i.e., carpal tunnel or trigger ﬁnger release), fracture proce-
dure (i.e., any fracture reduction with internal ﬁxation), or joint procedure
(i.e., arthroscopy, arthrodesis, or arthroplasty). The types of anesthesia were
divided into local anesthesia, local anesthesia with sedation, regional anes-
thesia with or without sedation, and general anesthesia. Finally, patient de-
mographic characteristics, such as age, sex, and type of insurance, were also
collected.
Statistical Analysis
The overall data were examined by descriptive statistics between the means.
The mean number of pills used and the mean total number of days used were
calculated on the basis of patient demographic characteristics (age, sex, and
insurance type), procedure, anesthesia, injection, and volume of injection.
The percentage of the total prescription used was calculated by dividing the
number of pills taken by the total number of pills prescribed. Single-factor
analysis of variance (ANOVA) was conducted to assess signiﬁcance (p < 0.05)
between the categorical variables and the continuous variables (number
of pills and number of days). Post hoc comparisons were performed using
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t tests, with the p value for multiple pairwise tests adjusted by the Bonferroni
correction.
Results
A total of 1,416 patients (639 male patients and 777 female
patients) with a mean age of 56 years (range, 18 to 93 years)
were included (Table I). Surgeons prescribed a mean total of
24 pills (median, 20 pills [range, 0 to 110 pills]) per surgical
procedure. Overall, the mean postoperative reported opioid
consumption was 8.1 pills (median, 4 pills [range, 0 to 90
pills]) for a mean time of 3.1 days, resulting in a utilization
rate of 34%.
Overall Opioid Consumption Pattern
Overall, 28.3% of patients did not take any of their prescribed
medications. An additional 56.1% of patients voluntarily dis-
continued the use of their prescription prior to its completion.
In contrast, 11.0% of patients completed the entirety of their
prescription, and 0.6% were still taking their medication at the
time of their ﬁrst postoperative visit. Finally, 4.0% did not wish
to participate and did not respond.
Opioid Consumption by Age
The mean reported number of opioid pills consumed was
highest (13.4 pills) among patients in the age group of 30
















18 to 19 yr 20 20 12.7 20 5.0 57.3
20 to 29 yr 103 102 12.7 98 4.1 45.8
30 to 39 yr 120 120 13.4 111 4.9 47.3
40 to 49 yr 200 199 10.0 186 3.6 29.8
50 to 59 yr 335 329 8.4 302 3.2 27.7
60 to 69 yr 335 332 6.8 308 2.6 21.7
70 to 79 yr 215 212 4.6 198 2.1 19.9
80 to 89 yr 84 81 3.2 73 1.6 12.8
90 to 100 yr 4 4 12.8 4 4.8 43.3
Sex
Female 777 769 7.9 712 2.9 25.8
Male 639 631 8.6 589 3.4 30.8
Insurance
Private 910 900 8.1 840 4.7 27.9
Medicare 372 367 5.4 340 3.0 19.8
Automotive Association 10 10 13.1 10 4.6 45.3
Workers’ Compensation 116 113 16.0 103 7.2 52
Self-pay or Medicaid 8 8 25.6 8 7.5 66
Procedure type
Soft tissue 904 893 5.1 839 2.2 20.9
Fracture 260 257 13.0 243 4.5 39.4
Joint 252 242 14.5 252 5.0 46.4
Procedure location
Hand 593 586 7.7 557 2.9 27
Wrist 658 651 7.5 600 3.1 27
Elbow or forearm 141 141 11.1 128 4.0 35
Upper arm or shoulder 24 23 22.0 14 6.0 56.6
Anesthesia*
Local 286 285 4.5 250 2.0 16.3
Local with sedation 601 590 5.7 542 2.6 25
Regional 172 172 15.0 151 4.8 42.7
General 337 333 12.5 315 4.0 38.2
*Twenty patients did not undergo any anesthesia.
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to 39 years (p < 0.001 according to ANOVA). Although the
ANOVA and visual inspection of the graph make it clear that
there is a real trend, pairwise tests between adjacent age groups
(adjusted for 8 multiple comparisons) were only signiﬁcant (p =
0.03) for the age groups of 60 to 69 years and 70 to 79 years. In fact,
47.3% of patients in the age groups of 30 to 39 years consumed
their entire prescription. Subsequently, there was a decrease in
opioid consumption in each successive age interval thereafter (from
the ages of 40 to 89 years), with the lowest amount consumed in the
age group of 80 to 89 years. There was a paradoxical increase in
opioid consumption in the age group of 90 to 100 years, although
this was a small sample group of only 4 patients (Fig. 1).
Patients in the age range of 30 to 39 years had the highest
reported mean opioid consumption for both soft-tissue pro-
cedures, at 11.6 pills, and joint procedures, at 19.2 pills. Patients
in the age group of 18 to 19 years who received treatment for
fracture ﬁxation reported the highest mean consumption, at
18.9 pills.
On the basis of the anatomic location, patients in the age
group of 18 to 19 years reported the highest mean opioid con-
sumption for hand andwrist procedures (12.8 pills) and for elbow
and forearm procedures (19.7 pills). Patients in the age group of
50 to 59 years showed the highest opioid consumption (32.5 pills)
for upper arm and shoulder procedures. Lastly, patients in the age
group of 20 to 29 years reported the highest mean opioid con-
sumption (13.8 pills) for hand and wrist procedures.
Opioid Consumption by Sex
Male patients reported taking a mean number of 8.6 pills for
3.4 days, whereas female patients reported taking a mean
number of 7.9 pills for 2.9 days postoperatively (Fig. 2).
There was no signiﬁcance in opioid consumption based on
sex (p = 0.20).
Opioid Consumption by Insurance
Based on insurance type, patients who self-pay or have Med-
icaid reported consuming the greatest amount of opioids, at a
mean number of 25.6 pills (p < 0.001 according to ANOVA)
for 7.5 days. Patients with Workers’ Compensation reported
consuming the next greatest amount, with a mean consump-
tion of 16 pills for 7.2 days. Patients with private insurance
carriers consumed a mean number of 8.1 pills for 4.7 days,
and Medicare patients, traditionally representing patients
who are ‡65 years of age, reported having consumed the least
Fig. 1
The mean number of pills and days by age. The error bars indicate the
standard deviation.
TABLE II Most Common Surgical Procedures by Procedure Type
Procedure No. of Patients Mean No. of Pills Taken
Soft tissue
Carpal tunnel release 380 4.2
Trigger ﬁnger release 155 3.8
Mass excision 95 4.7
Fracture
Distal radial open reduction internal ﬁxation 114 13.7
Metacarpal open reduction internal ﬁxation 46 9.6
Finger pinning 23 8.1
Joint
Implant removal 39 12.3
Carpometacarpal arthroplasty 31 21.5
Tendon repair 28 14.5
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amount, with a mean number of 5.4 pills for 3 days (Fig. 3). Post
hoc comparisons between groups showed signiﬁcant differences
between patients with private insurance and those with Medicare
(p< 0.001), between patientswith private insurance and thosewith
Workers’ Compensation (p < 0.001), and between patients with
Medicare and those with Workers’ Compensation (p < 0.001).
TABLE III Most Common Procedures by Anatomic Site
Procedure No. of Patients No. of Pills Taken
Hand
Trigger ﬁnger release 155 3.8
Mass excision 58 4.3
Metacarpal open reduction internal ﬁxation 46 9.6
Wrist
Carpal tunnel release 380 4.2
Distal radial open reduction internal ﬁxation 114 13.7
De Quervain tenosynovitis 40 7.9
Elbow or forearm
Cubital tunnel release 42 8.9
Lateral epicondyle debridement 23 13.5
Distal biceps repair 13 11.1
Shoulder or upper arm
Acromioplasty rotator cuff 7 21.4
Humeral open reduction internal ﬁxation 4 53.5
Distal clavicle resection 2 31.0
Fig. 2 Fig. 3
Fig. 2 The mean number of pills and days by sex. The error bars indicate the standard deviation. Fig. 3 The mean number of pills and days by
insurance type. The error bars indicate the standard deviation. Auto = Automotive Association.
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Opioid Consumption by Procedure Type
Patients who underwent soft-tissue procedures reportedly
consumed the least amount of opioids postoperatively, with
a mean number of 5.1 pills (p < 0.001, ANOVA) for 2.2 days,
compared with those who underwent fracture procedures
(13.0 pills for 4.5 days) or joint procedures (14.5 pills for
5.0 days) (Fig. 4). When compared with adjacent groups,
there were signiﬁcant differences between patients who
underwent soft-tissue procedures and those who under-
went fracture procedures (p < 0.001) and between patients
who underwent soft-tissue procedures and those who
underwent joint procedures (p < 0.001). The most common
surgical procedures performed in these categories are listed
in Table II.
Opioid Consumption by Anatomic Site
Patients who had undergone hand and wrist surgical pro-
cedures reported the least opioid consumption, with those
who had undergone hand surgical procedures having a
mean number of 7.7 pills for 2.9 days and those who had
undergone wrist surgical procedures having a mean num-
ber of 7.5 pills for 3.1 days (p < 0.001). However, post hoc
pairwise comparisons adjusted for 3 multiple comparisons
showed signiﬁcance for procedures on the wrist compared
with those on the elbow (p = 0.008). Patients who had
undergone upper arm and shoulder surgical procedures
had the greatest mean reported opioid consumption with
22.0 pills for 6.0 days. Patients who had undergone elbow
and forearm surgical procedures had a reported mean opi-
oid consumption of 11.1 pills for 4.0 days (Fig. 5). The most
common surgical procedures in these categories are listed
in Table III.
Opioid Consumption by Anesthesia Type
Patients who had undergone surgical procedures with only
local anesthesia reportedly consumed the fewest opioids (p <
0.001), at a mean number of 4.5 pills for 2.0 days, compared
with patients who had undergone surgical procedures with
anesthesia with sedation (5.7 pills for 2.6 days), those who
had undergone surgical procedures with general anesthesia
(12.5 pills for 4.0 days), and those who had undergone surgical
procedures with regional anesthesia (15.0 pills for 4.8 days)
(Fig. 6). When a post hoc pairwise comparison was used to
compare adjacent groups (6 groups), all groups were found
to be signiﬁcant (p < 0.001), except when patients who under-
went local anesthesia were compared with those who under-
went local anesthesia with sedation (p = 0.118) and when
patients who underwent regional anesthesia were compared
with those who underwent general anesthesia (p = 0.621).
However, it should be noted that patients typically undergoing
general or regional anesthesia do so for more involved or pain-
ful surgical procedures such as fracture, joint, or upper arm
Fig. 4 Fig. 5
Fig. 4 The mean number of pills and days by procedure. The error bars indicate the standard deviation. Fig. 5 The mean number of pills and days
by anatomic location. The error bars indicate the standard deviation.
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surgical procedures. Hence, the relationship between opioid
consumption and anesthesia type is an inherently biased one.
Opioid Disposal Instructions
Only 5.3% of patients who ﬁlled their prescription received
disposal information (n = 75). The sources of disposal
information listed included the physician, recovery room
nurses, and the pharmacy.
Discussion
There is a growing epidemic in the United States involving the
misuse of prescription opioids. In 2013, The Journal of the
American Medicine Association reported that there had been
38,329 drug overdose deaths in the United States in 2010, and
75.2% of these deaths involved prescription opioids7. Amer-
icans, who make up 4.6% of the world’s population, consume
80% of the global opioid supply8. As the United States reports
substantial opioid abuse, the number of opioid-related deaths
continues to grow internationally with increasing availability
of opioids9. A Global Burden of Diseases, Injuries, and Risk
Factors Study found that there were an estimated 43,000
deaths worldwide in 2010 due to opioid abuse10.
Several studies have shown that opioids are being in-
advertently overprescribed to patients postoperatively across
all specialties, but especially in orthopaedic surgical proce-
dures3,4,11. Stanek et al.12 studied opioid-prescribing patterns
by implementing a new prescribing protocol for patients un-
dergoing common upper-extremity surgical procedures. An
educational card with a multimodal pain management plan
was given to participating physicians with speciﬁc opioid rec-
ommendations. No narcotics were recommended for small
procedures such as Mohs excisions, trigger ﬁnger releases, or
retinacular cyst, nevi, lump, or bump excision. Ten narcotic
pills were recommended for small procedures such as mucous
cyst excisions, carpal tunnel releases, de Quervain releases,
Dupuytren excisions, nonoperative hand fractures, and small
joint arthrodeses. Twenty narcotic pills were recommended for
wrist ganglion excisions, hand fracture ﬁxation, basal joint ar-
throplasty, and tendon surgical procedures. Finally, 40 narcotic
pills were recommended for larger surgical procedures such as
wrist arthrodeses and reconstructions12. After implementing
the new protocol, Stanek et al. found a decrease in opioid pre-
scribing of 15% for trigger ﬁnger release, 20% for metacarpal
fracture repair, 48% for wrist cyst excision, and 39% for de
Quervain release12.
In a study of 250 patients, Rodgers et al. evaluated pa-
tient pain control after elective outpatient upper-extremity
surgical procedures and quantiﬁed the number of leftover
pain medications up to 14 days postoperatively11. The authors
found that bone procedures resulted in the greatest opioid
consumption (14 pills) and soft-tissue procedures had the
lowest consumption (9 pills). Overall, a mean of 10 opioid
pills were consumed per patient, and 19 pills were left unused
and available for potential abuse11. Similar results were found
in our study, in which only 11.0% of 1,416 patients completed
the entirety of their prescription. Moreover, surgeons in our
series prescribed a mean number of 24 pills, but the reported
mean postoperative consumption was only 8.1 pills, resulting
in a utilization rate of 34%. The result was that 66% of the
prescription was available for potential diversion or abuse. In
fact, during our study period alone, with 9 surgeons over 6
months, a total of 21,788 theoretically unused prescribed opi-
oid pills was delivered into the community. Results from the
2010 National Survey on Drug Use and Health showed that
about 5.1 million drug users (of 22.6 million illicit drug users)
used prescription pain relievers; only 1 in 6 or 17.3% recorded
that they had received the drugs through a prescription from
their doctor13.
One of the challenges of excess opioid prescribing is
safe disposal. Per the U.S. Food and Drug Administration
(FDA), certain opioids can be ﬂushed away, but others require
deliberate elimination14. The FDA currently recommends that
opioids be disposed of via pharmacy or community take-
back programs or by mixing them in the household trash
with substances such as coffee grounds or cat litter in a sealed
bag. A complete list of which medicines can be ﬂushed away
is available on the FDA web site 14. However, the U.S. Envi-
ronmental Protection Agency (EPA) discourages ﬂushing any
medications away to avoid contamination of the water sup-
ply15. Unfortunately, unclear opioid disposal practices were
Fig. 6
The mean number of pills and days by anesthesia. The error bars indicate
the standard deviation.
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found to be common in our study population. Only 5.3% of
the 1,416 patients received any disposal information for excess
opioids from their physician, nurses, or pharmacists. McCauley
et al. similarly reported ﬁndings from aweb-based intervention
study that was designed to improve patient knowledge of safe
medication use, storage, and disposal16. Of 62 patients, they
found that one-third were unaware of the unsafe nature of
retained leftover opioid pills and almost half of their cohort
did not know where to or how to properly dispose of pre-
scription opioids16. In our cohort, 94% of patients did not
receive safe disposal information. Medical staff should be
more aware and vigilant in properly educating patients on
safe disposal of excess opioid medication.
Patients undergoing orthopaedic surgical procedures
have been shown to have higher pain postoperatively compared
with those undergoing surgical procedures in other special-
ties17-19. Ringwalt et al. found that orthopaedic surgeons have
the highest odds (7.1 to 1) of prescribing opioids to Medicare
patients compared with other medical providers, such as den-
tists or emergency medicine physicians20. Yet it has been shown
that orthopaedic surgeons have the highest patient return rate
to the hospital for persistent postoperative pain21. Our ﬁndings
support these facts, as the study surgeons were routinely prescrib-
ing in excess of their patients’ needs and utilization. Upon infor-
mally surveying the participating surgeons, the most common
reasons given for prescribing the amount that they did were to
avoid undermanaging postoperative pain, to minimize patient
calls, and to limit hospital readmissions. However, this “defen-
sive” overprescribing increases the number of opioids in the com-
munity available for potential diversion or abuse. Based on our
series, risk factors for increased opioid consumption include
younger age (patients in the age group of 30 to 39 years consumed
the greatest opioids), certain insurance types (self-pay, Medicaid,
and Workers’ Compensation), fracture or joint surgical proce-
dures, and surgical procedures involving the upper arm.
Opioid consumption was found to be most strongly
statistically related to procedure type and anatomic location.
Therefore, based on our study ﬁndings, we recommend
that surgeons consider these general guidelines for pre-
scribing opioids postoperatively after outpatient upper-
extremity surgical procedures to optimize the number of
opioids dispensed: £10 opioids for hand and wrist soft-
tissue surgical procedures, £20 opioids for hand and wrist
fracture or joint surgical procedures, £15 opioids for elbow
and forearm soft-tissue surgical procedures, £20 opioids
for elbow and forearm fracture or joint surgical procedures,
and £30 opioids for upper arm and shoulder surgical
procedures.
There were some limitations to this study. First, because
of the subjective nature of patient recall, some patients may
have overestimated or may have underestimated the number
of pills and/or number of days that the opioid was used. Fur-
thermore, our study included all patients who were undergo-
ing an upper-extremity procedure, and therefore, it may have
included patients with chronic pain who were currently tak-
ing opioids and had a predisposed tolerance for opioids. In
addition, information on preoperative nicotine use was not
collected. Nicotine can potentially affect postoperative opioid
consumption and pain experience. Lastly, a few patients did
not ﬁll out the entirety of the survey, thereby potentially
skewing the results (speciﬁcally, of 1,416 enrolled patients,
16 patients did not report the total number of pills used,
115 patients did not report the total number of days that the
pills were taken, and 56 patients did not report the reason for
discontinuation).
In conclusion, the pattern of prescribing high volumes
of opioid pills is a common practice among orthopaedic surgeons.
Overprescribing delivers excess opioids into the community, leav-
ing them vulnerable to potential diversion or abuse. To avoid
overprescribing opioids and to limit potential abuse, surgeons
should consider the patient’s preoperative opioid experience and
should establish prescribing standards on a case-by-case basis
depending on the nature and location of the surgical procedure,
the type of anesthesia, and the age of the patient. n
Nayoung Kim, BS1
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